Abstract
There is a perception that tamoxifen causes weightgain in breast cancer patients. The purpose ofthis research study was to determine if weightgain is associated with tamoxifen therapy and toobserve the impact of weight gain on recurrenceand survival. Prognostic indicators, changes in weight, anddisease status from diagnosis to the end oftreatment were studied in 200 consecutive Stage Iand II breast cancer patients, not receiving systemicchemotherapy, admitted from 1986 to the present, withobservation periods ranging from 3–5 years. A meanweight gain of 1.2 Kgs was seen inall patients; however, weight gain was not significantlydifferent for those receiving tamoxifen vs. those notreceiving tamoxifen, (P=0.66, CI 95% forthe difference –1.8 Kgs to +1.2 Kgs). Weightgain during treatment with tamoxifen was not correlatedwith treatment duration or with recurrence or survival.Age at diagnosis was positively correlated to weightgain in all groups. Our data failed toshow that tamoxifen is associated with weight gain.The moderate weight gain observed in this patientpopulation is comparable to the general aging disease-freepopulation and may not be treatment-related. These findingsmay help to alleviate some concerns of bothphysicians and patients when tamoxifen is the drugof choice for adjuvant therapy.
Similar content being viewed by others
References
American Cancer Society Inc.: Cancer Facts & Figures (ACS Publication no. 5008.95). Atlanta, GA, 1995
Dixon J, Moritz DA, Baker FL: Breast cancer and weight gain: An unexpected finding. Oncology Nursing Forum 5: 5–7, 1978
Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH: Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 8: 1327–1334, 1990
Demark-Wahnefried W, Winer EP, Rimer BK: Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 11: 1418–1429, 1993
Chlebowski RT, Weiner JM, Reynolds R, Luce J, Bulcavage L, Bateman JR: Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 7: 23–29, 1986
Levine EG, Racqynski JM, Carpenter JT: Weight gain with breast cancer adjuvant treatment. Cancer 67: 1954–1959, 1991
Goodwin PJ, Panzarella T, Boyd NF: Weight gain in women with localized breast cancer — a descriptive study. Breast Cancer Res Treat 11: 59–66, 1988
Ballard-Barbash R: Anthropometry and breast cancer. Body size — a moving target. Cancer 74:Suppl 1090–1100, 1994
Gray R: Tamoxifen: How boldly to go where no women have gone before. J Nat Cancer Inst 85: 1358–1360, 1993
Chlebowski RT, Butler J, Nelson A, Lillingto L: Breast cancer chemoprevention. Cancer 72: 1032–1037, 1993
Powles TJ: The case for clinical trials of tamoxifen for prevention of breast cancer. The Lancet 340: 1145–1147, 1992
Hoskin PJ, Ashley S, Yarnold JR: Weight gain after primary surgery for breast cancer. Breast Cancer Res Treat 22: 129–132, 1992
Rose DP, Connolly JM, Chlebowski RT, Buzzard IM, Wynder EL: The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of post-menopausal breast cancer patients. Breast Cancer Res Treat 27: 253–262, 1993
Wade GN, Gray JM, Blaustein JD: Effects of estrogens and antiestrogens on eating behavior, metabolism and energy balance. Oncology 7: 61–68, 1993
DeConti R: Weight gain in the adjuvant chemotherapy of breast cancer. Proc ASCO: C-143, 1981 (Abstr)
Donegan WL, Hartz AJ, Rimm AA: The association of body weight and recurrent cancer of the breast. Cancer 41: 1590–1594, 1978
Boyd NF, Campbell JE, Germanson T, Thomson DB, Sutherland DJ, Meakin JW: Body weight and prognosis in breast cancer. J Natl Cancer Inst 67: 785–789, 1981
Tartter PE, Papatestas AE, Iannovitch J, Mulvihill MN, Lesnick G, Aufses AH: Cholesterol and obesity as prognostic factors in breast cancer. Cancer 47: 2222–2227, 1981
Zumoff B, Gorzynski JG, Katz JL, Weiner H, Levin J, Holland J, Fukushima DK: Nonobesity at the time of mastectomy is highly predictive of 10 year disease free survival in women with breast cancer. Anticancer Res 2: 59–62, 1982
Ederlein T, Simon R, Fisher S, Lippman ME: Height, weight, and risk of breast cancer relapse. Breast Cancer Res Treat 5: 81–86, 1985
Abe R, Kumagai N, Kimura M, Hirosaki A, Nakamura T: Biological characteristics of breast cancer in obesity. Tohoku J Exp Med 120: 351–359, 1976
DeGeorge D, Gray JJ, Fetting JH, Rolls BJ: Weight gain in patients with breast cancer receiving adjuvant treatment as a function of restraint, disinhibition, and hunger. Oncology Nursing Forum (supp) 17: 23–30, 1990
Schag AC, Ganz PA, Polinsky ML, Fred C, Hirji K, Petersen L: Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 11: 783–793, 1993
O'Brien BJ, Rusthoven J, Rocchi A, Latreille J, Fine S, Vandenberg T, Laberge F: Impact of chemotherapy-associated nausea and vomiting on patients' functional status and costs: Survey of five Canadian centres. Can Med Assoc J 149: 295–304, 1993
Knobf MT: Physical and psychological distress associated with adjuvant chemotherapy in women with breast cancer. J Clin Oncol 4: 678–684, 1986
Morrow GR, Asbury R, Hammon S et al.: Comparing the effectiveness of behavioral treatment for chemotherapy-induced nausea and vomiting when administered by oncologists, oncology nurses and clinical psychologists. Health Psychology 11: 250–256, 1992
Cimprich B: A theoretical perspective on attention and patient education. Advances in Nursing Science 14: 39–51, 1992
Nail L, Jones L, Greene D et al.: Use and perceived efficacy of self-care activities in patients receiving chemotherapy. Oncology Nursing Forum 18: 883–887, 1991
Winningham ML, Nail LM, Burke MB, Brophy L, Cimprich B, Jones LS, Pickard-Holley S, Rhodes V, St. Pierre B, Beck S: Fatigue and the cancer experience: The state of knowledge. Oncology Nursing Forum 21: 23–26, 1994
Svendsen OL, Hassager C, Christiansen C: Age-and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 44: 369–373, 1995
Wade GN, Gray JM, Blaustein JD: Effects of estrogens and anti-estrogens on eating behavior, metabolism, and energy balance. Cancer 7(suppl): 61–68, 1993
DenBesten C, Vansant G, Westrate JA, Deurenberg P: Resting metabolic rate and diet-induced thermogenesis in abdominal and gluteal-femoral obese women before and after weight reduction. Am J Clin Nutr 47: 840–847, 1988
Poehlman ET, Toth MJ, Gardner AW: Changes in energy balance and body composition at menopause: A controlled longitudinal study. Ann Intern Med 123: 673–675, 1995
Haarbo J, Marslew U, Gotfredson A, Christiansen C: Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40: 1323–1326, 1991
Wang Q, Hassager C, Ravn P, Wang S, Christiansen C: Total and regional body-composition changes in early postmenopausal women: age-related or menopause-related? Am J Clin Nutr 60: 843–848, 1994
Wing RR: Obesity and weight gain during adulthood: A health problem for United States women. Women's Health Issues 2: 114–122, 1992
Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL: Weight gain at the time of menopause. Arch Int Med 151: 97–103, 1991
Williamson DF, Kahn HS, Patrick RL, Anda RF: The 10-year incidence of overweight and major weight gain in US adults. Arch Int Med 150: 665–672, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kumar, N., Allen, K., Cantor, A. et al. Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?. Breast Cancer Res Treat 44, 135–143 (1997). https://doi.org/10.1023/A:1005721720840
Issue Date:
DOI: https://doi.org/10.1023/A:1005721720840